Tarsus Pharmaceuticals (TARS)
(Delayed Data from NSDQ)
$34.64 USD
+2.09 (6.42%)
Updated Sep 19, 2024 03:59 PM ET
Pre-Market: $34.40 -0.20 (-0.58%) 9:20 AM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.89 | -2.63% |
Earnings Summary
For their last quarter, Tarsus Pharmaceuticals (TARS) reported earnings of -$0.88 per share, beating the Zacks Consensus Estimate of $-0.98 per share. This reflects a positive earnings surprise of 10.20%. Look out for TARS's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.89 per share, reflecting a year-over-year increase of 30.47%.
Earnings History
Price & Consensus
Zacks News for TARS
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
TARS: What are Zacks experts saying now?
Zacks Private Portfolio Services